State to divert entire Covaxin stock for 45+ Maharashtra has put the brakes on vaccination of persons in the 18-44 years age group and will use the available stock to provide second dose for those above 45 years. The decision has been taken because of non-availability of adequate stock of Covid-19 vaccines, Maharashtra health minister Rajesh Tope said on Tuesday. The state health department has announced diverting the entire stock of 275,000 Covaxin doses, which it had procured for the 18-44 age group, to vaccinate those above 45 years. Doses of Serum Institute of India’s Covishield vaccine meant for 18-44 years too could be diverted for the 45 plus group. Tope indicated challenges in procuring doses but did not disclose the quantum of Covishield which could be diverted. As of now, no instruction has been issued to districts on diverting Covishield doses. While Maharashtra has declared it would divert Covaxin doses meant for 18-44 years, seven other states had last week flagged off sho...